N-methyl-imidazole derivatives for treating mycotic infections
AssigneeBayer Aktiengesellschaft
InventorsWilfried Draber, Karl Heinz Buchel, Erik Regel, Manfred Plempel
Life of this patent
Estimating the term…
Loading patent…
AssigneeBayer Aktiengesellschaft
InventorsWilfried Draber, Karl Heinz Buchel, Erik Regel, Manfred Plempel
Estimating the term…
N-methyl-imidazole derivatives of the formula: ##STR1## or a pharmaceutically acceptable non-toxic salt thereof, wherein X is an unsubstituted or substituted 6-membered heteroaromatic moiety having two nitro heteroatoms, Y is an unsubstituted or substituted aliphatic moiety, an unsubstituted or substituted cycloaliphatic moiety, an unsubstituted or substituted aralkyl moiety or an unsubstituted or substituted aryl moiety, and Z is an unsubstituted or substituted aliphatic moiety, an unsubstituted or substituted cycloaliphatic moiety, an unsubstituted or substituted aralkyl moiety, an unsubstituted or substituted aryl moiety, an unsubstituted or substituted pyridyl moiety or an alkoxycarbonyl moiety, Are useful as antimycotic agents.
A pharmaceutical composition for treating mycotic infections in humans and animals which comprises an antimycotically effective amount of a compound of the formula:
Dependencies are inferred from the claim text.